Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • giorgifm
    Member
    • Aug 2011
    • 35

    #1

    EMS causal mutation identification by NGS

    Dear all,

    I was recently struck by this paper http://www.ncbi.nlm.nih.gov/pubmed/21398646 where the authors used 75bp Illumina NGS to identify EMS-induced mutations in Arabidopsis. The procedure involves crossing two ecotypes and sequencing (1) the parental ecotype A, (2) the parental ecotype B and (3) the F2 generation with phenotype suppression.
    My question is: if one had to repeat this study, what would be the absolute minimum coverage for obtaining a chance for a reliable SNP detection? Assuming re-sequencing of the parental lines too. In the paper they suggest 6x-9x, so if I understand correctly one run with modern Illumina machines will be sufficient for the entire experiment, assuming perhaps nuclei extraction.

    Thanks a lot
    Last edited by giorgifm; 01-09-2012, 12:45 AM.
  • iansealy
    Member
    • Oct 2010
    • 15

    #2
    http://www.genetics.org/content/earl...1.136069.short might be of interest.

    Cheers,
    Ian

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Working...